Logo image of VHC

VIRNETX HOLDING CORP (VHC) Stock Fundamental Analysis

USA - NYSE:VHC - US92823T2078 - Common Stock

17.0974 USD
+1.08 (+6.73%)
Last: 9/18/2025, 8:04:00 PM
17.4 USD
+0.3 (+1.77%)
After Hours: 9/11/2025, 8:20:44 PM
Fundamental Rating

2

Overall VHC gets a fundamental rating of 2 out of 10. We evaluated VHC against 280 industry peers in the Software industry. While VHC has a great health rating, there are worries on its profitability. VHC has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

VHC had negative earnings in the past year.
VHC had a negative operating cash flow in the past year.
VHC had negative earnings in 4 of the past 5 years.
In the past 5 years VHC reported 4 times negative operating cash flow.
VHC Yearly Net Income VS EBIT VS OCF VS FCFVHC Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100M -100M 200M

1.2 Ratios

The Return On Assets of VHC (-41.50%) is worse than 83.57% of its industry peers.
Looking at the Return On Equity, with a value of -52.32%, VHC is doing worse than 70.36% of the companies in the same industry.
Industry RankSector Rank
ROA -41.5%
ROE -52.32%
ROIC N/A
ROA(3y)-35.49%
ROA(5y)-2.01%
ROE(3y)-39.82%
ROE(5y)-3.53%
ROIC(3y)N/A
ROIC(5y)N/A
VHC Yearly ROA, ROE, ROICVHC Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -200 -400 -600 -800 -1K

1.3 Margins

The Profit Margin and Operating Margin and Gross Margin are not available for VHC so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
VHC Yearly Profit, Operating, Gross MarginsVHC Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100K -100K -200K -300K -400K

More info and screens

7

2. Health

2.1 Basic Checks

VHC does not have a ROIC to compare to the WACC, probably because it is not profitable.
VHC has more shares outstanding than it did 1 year ago.
VHC has more shares outstanding than it did 5 years ago.
VHC has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
VHC Yearly Shares OutstandingVHC Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1M 2M 3M 4M
VHC Yearly Total Debt VS Total AssetsVHC Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M

2.2 Solvency

VHC has an Altman-Z score of -3.00. This is a bad value and indicates that VHC is not financially healthy and even has some risk of bankruptcy.
Looking at the Altman-Z score, with a value of -3.00, VHC is doing worse than 80.36% of the companies in the same industry.
VHC has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z -3
ROIC/WACCN/A
WACC11.02%
VHC Yearly LT Debt VS Equity VS FCFVHC Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100M 200M

2.3 Liquidity

VHC has a Current Ratio of 16.26. This indicates that VHC is financially healthy and has no problem in meeting its short term obligations.
With an excellent Current ratio value of 16.26, VHC belongs to the best of the industry, outperforming 97.50% of the companies in the same industry.
VHC has a Quick Ratio of 16.26. This indicates that VHC is financially healthy and has no problem in meeting its short term obligations.
The Quick ratio of VHC (16.26) is better than 97.50% of its industry peers.
Industry RankSector Rank
Current Ratio 16.26
Quick Ratio 16.26
VHC Yearly Current Assets VS Current LiabilitesVHC Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M

More info and screens

1

3. Growth

3.1 Past

The Earnings Per Share has grown by an nice 14.38% over the past year.
VHC shows a strong growth in Revenue. In the last year, the Revenue has grown by 1566.67%.
VHC shows a very negative growth in Revenue. Measured over the last years, the Revenue has been decreasing by -43.90% yearly.
EPS 1Y (TTM)14.38%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%7.2%
Revenue 1Y (TTM)1566.67%
Revenue growth 3Y-50%
Revenue growth 5Y-43.9%
Sales Q2Q%4900%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
VHC Yearly Revenue VS EstimatesVHC Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M
VHC Yearly EPS VS EstimatesVHC Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 -2 -4 -6 -8

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for VHC. In the last year negative earnings were reported.
Industry RankSector Rank
PE N/A
Fwd PE N/A
VHC Price Earnings VS Forward Price EarningsVHC Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
VHC Per share dataVHC EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 -2 4 -4 6

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

VHC does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

VIRNETX HOLDING CORP

NYSE:VHC (9/18/2025, 8:04:00 PM)

After market: 17.4 +0.3 (+1.77%)

17.0974

+1.08 (+6.73%)

Chartmill FA Rating
GICS IndustryGroupSoftware & Services
GICS IndustrySoftware
Earnings (Last)08-12 2025-08-12/amc
Earnings (Next)11-11 2025-11-11
Inst Owners10.86%
Inst Owner Change-5.43%
Ins Owners14.59%
Ins Owner Change5.12%
Market Cap73.01M
Analysts0
Price TargetN/A
Short Float %3.35%
Short Ratio7.1
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly Dividend0
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 1460.12
P/FCF N/A
P/OCF N/A
P/B 2.2
P/tB 2.2
EV/EBITDA N/A
EPS(TTM)-4.8
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-3.65
FCFYN/A
OCF(TTM)-3.64
OCFYN/A
SpS0.01
BVpS7.77
TBVpS7.77
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -41.5%
ROE -52.32%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-35.49%
ROA(5y)-2.01%
ROE(3y)-39.82%
ROE(5y)-3.53%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score5
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 52.38%
Cap/Sales 22%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 16.26
Quick Ratio 16.26
Altman-Z -3
F-Score5
WACC11.02%
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)456.19%
Cap/Sales(5y)273.71%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)14.38%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%7.2%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)1566.67%
Revenue growth 3Y-50%
Revenue growth 5Y-43.9%
Sales Q2Q%4900%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y16.31%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y35.38%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y35.42%
OCF growth 3YN/A
OCF growth 5YN/A